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Abstract
Background: Arterial stiffness predicts the future risk of macro- and micro-vascular diseases. Only a few studies
have reported longitudinal changes. The present study aimed to investigate the progression rate of arterial stiffness
and the factors influencing stiffness progression in a Han Chinese population residing in Taiwan.
Methods: The pulse wave velocity (PWV), elasticity modulus (Ep) and arterial stiffness index (β) of the common
carotid artery were measured in 577 stroke- and myocardial infarction-free subjects at baseline and after an average
interval of 4.2 ± 0.8 years. Stepwise multivariate linear regression was conducted to elucidate the predictors of
stiffness progression.
Results: For both baseline and follow-up data, men had significantly higher values of PWV, Ep and β in comparison
to women. The progression rates of PWV, Ep and β were faster in men, but the difference was not statistically
significant (ΔPWV = 0.20 ± 0.20 and 0.18 ± 0.20 m/s/yr; ΔEp = 8.17 ± 8.65 and 6.98 ± 8.26 kPa/yr; Δβ = 0.70 ± 0.64
and 0.67 ± 0.56 for men and women, respectively). In the multivariate regression analyses, age, baseline stiffness
parameters, baseline mean arterial pressure (MAP), baseline body mass index (BMI) and changes in MAP (ΔMAP)
were independent predictors of PWV and Ep progression. There was an inverse correlation between the stiffness
parameters at baseline and their progression rate (correlation coefficient (r) = −0.12 to −0.33, p = 0.032–1.6 × 10−16).
Changes in MAP (ΔMAP) rather than baseline MAP were more strongly associated with PWV progression
(p = 8.5 × 10−24 and 1.9 × 10−5 for ΔMAP and baseline MAP, respectively). Sex-specific analyses disclosed that
baseline BMI and changes in BMI (ΔBMI) were significantly associated with stiffness progression in men
(p = 0.010–0.026), but not in women.
Conclusions: Aging and elevated blood pressure at baseline and during follow-up were the major determinants
of stiffness progression in the Han Chinese population. For men, increased baseline BMI and changes in BMI were
additional risk factors.
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Background
Arterial stiffness, which is caused by the loss of normal
elastin and the increase of abnormal collagen, is one of the
earliest functional changes in the vascular aging process
[1]. Previous studies have shown that increased arterial
stiffness is strongly associated with atherosclerosis [2].
Arterial stiffness predicts future risk of coronary heart dis-
ease, stroke, and cardiovascular mortality in high-risk and
general populations [3–5]. In addition, arterial stiffness
contributes to the hypertrophy and remodeling of micro-
circulation [6], which leads to microvascular diseases, such
as diabetic retinopathy and lacunar infarction [7, 8]. Eluci-
dating the determinants of arterial stiffness could pave
the way toward the management and prevention of
both macro- and micro-vascular diseases.
The established risk factors for arterial stiffening include
aging, elevated blood pressure (BP), impaired glucose me-
tabolism, hyperlipidemia, and increased body mass index
(BMI) [9, 10]. Most studies evaluated stiffness parame-
ters in a cross-sectional manner; only a few large-
scale cohort studies reported the longitudinal changes
of stiffness [11–15]. The majority of the participants
in these longitudinal studies were Caucasians. The
MultiEthnic Study of Atherosclerosis enrolled only 308
Chinese, and according to MESA, Chinese subjects had
significantly worse profiles of arterial stiffness at baseline,
but the rate of arterial stiffening in Chinese subjects
during follow-up was similar to the rates in other ethnic
groups [13]. Only one longitudinal study investigated the
association between metabolic syndrome and brachial-
ankle PWV (baPWV) in a Taiwanese population [16], but
baPWV could not faithfully denote central arterial stiffness
[17]. The features of the progression of central arterial
stiffness in non-white populations remain unclear.
This longitudinal study aims to follow-up on the pro-
gression rate of arteriosclerosis in the Chinese population
residing in Taiwan. The present study reported the pro-
gression rate of arterial stiffness and the factors influen-
cing the progression of stiffness in this cohort. In addition,




The study participants were stroke- and myocardial
infarction-free individuals recruited from the community
population through an advertisement posted at the
Kaohsiung Medical University Hospital (KMUH) [18].
Carotid ultrasonography was performed in each partici-
pant for the measurement of arterial stiffness. From
November 2008 through March 2014, we contacted 579
subjects who completed baseline assessments between
August 2006 and August 2010. Two participants (0.3 %)
were lost to follow-up, and 577 persons received a second
carotid ultrasonographic study.
Each participant filled out a self-administered question-
naire, which included demographic information, previous
medical histories and smoking habits. BMI was calculated
as weight (kg)/ height squared (m2). BP was acquired
using a calibrated standard sphygmomanometer (Omron;
Vernon Hills, Illinois) after resting in the sitting position
for at least 5 min. The average value from two measure-
ments was used. Plasma concentrations of total
cholesterol (TC), high density lipoprotein-cholesterol
(HDL-C), fasting blood sugar (FBS), and triglyceride
(TG) were measured using standardized enzymatic pro-
cedures (Boehringer Mannheim, Germany). The study
was approved by the Institutional Review Board of
KMUH and written informed consent was provided by
each participant.
Measurement of arterial stiffness
Carotid stiffness was measured by an ultrasound with an
echo-tracking system (SSD-5500, Aloka, Tokyo, Japan)
equipped with a 3–12-MHz linear array transducer and
a vessel wall movement detector. Measurements were
performed in the right common carotid artery (CCA)
2 cm before the carotid bulb, and a longitudinal section
of the vessel was obtained in the B-mode. In the M-
mode, the vessel movement detector system registered
at least 10 consecutive cardiac cycles and the subsequent
changes in arterial diameter. Brachial BP was taken with
a semi-automated recorder before and after each ultra-
sound examination and was averaged. This procedure
was repeated three times, and the average data were
used for analyses [18, 19]. Three carotid stiffness parame-
ters were calculated automatically:
(1)Arterial stiffness index (β) = Ln (SBP / DBP)/[(Ds
−Dd)/ Dd] (SBP and DBP are the systolic and
diastolic BP; Ds and Dd are the systolic and
diastolic intra-luminal CCA diameters);
(2)Elasticity modulus (Ep) = (SBP −DBP)/[(Ds −Dd)/
Dd]; and
(3)One point pulse wave velocity (PWV) = √ (βDBP/
2ρ), where ρ is the constant of blood density
(1050 kg/m3).
PWV was conventionally measured using a “two-point”
method, while the Aloka ultrasound system provided a
valid, one-point measurement of PWV [20]. The intra-
reader correlation coefficient was 0.98 in β and Ep and
0.92 in PWV.
Definition of risk factors
The conventional risk factors for arterial stiffness in-
clude diabetes, hypertension, hyperlipidemia, obesity and
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smoking habit. A subject was defined as having diabetes if
he/she had FBS ≥126 mg/dl or was on hypoglycemic med-
ications. A subject was defined as having hyperlipidemia if
he/she had serum levels of TC ≥ 240 mg/dl or was on
hypolipidemic agents. Hypertension was defined as BP ≥
140/90 mmHg or was on anti-hypertensive medication.
Obesity was defined as BMI ≥ 25 kg/m2 according to the
Asian criteria proposed by International Association for
the Study of Obesity and the International Obesity Task
Force [21]. Because conventional risk factors might be
modified during follow-up, changes in mean arterial pres-
sure (ΔMAP), lipid profiles (ΔTC, ΔTG and ΔHDL-C),
FBS (ΔFBS) and BMI (ΔBMI) were used to quantitatively
measure the improvement of these risk factors. The
change in each risk factor parameter was calculated
by subtracting the value measured at follow-up by the
corresponding value upon enrollment.
Statistical analyses
Statistical analyses were performed using SPSS 19.0
(SPSS Inc., Chicago, IL, USA). A two-tailed p value < 0.05
was considered statistically significant. Data were pre-
sented as the means ± standard deviation (SD) or propor-
tions. The chi-squared test was used for categorical data,
while Student’s t-test was used for continuous data. Serum
TG levels were log-transformed to approximate the nor-
mal distribution. The annual progression rate of arterial
stiffness was defined as the difference of the individual
stiffness parameter divided by the follow-up interval
between two ultrasonography examinations. Pearson’s
correlation was used to evaluate the relationship between
stiffness progression rates and quantitative risk factors at
baseline, as well as the relationship between stiffness pro-
gression rates and changes in each risk factor parameter
during follow-up.
Stepwise multivariate linear regression was conducted
to investigate the predictive effect of age, baseline risk fac-
tors and changes in quantitative risk factors for stiffness
progression. Risk factors associated with progression rates
with a p value < 0.10 in the univariate analysis were in-
cluded in the multivariate regression model. All the statis-
tical analyses were repeated in sex-specific analyses.
Results
Demographic features
The demographic characteristics of the study subjects
are shown in Table 1. The average age at enrollment was
54.5 ± 9.2 years, and men accounted for 38.8 % of the
Table 1 Demographic features of study participants
% or mean ± SD All (N = 577) Women (N = 353) Men (N = 224)
Follow-up duration (y) 4.2 ± 0.8 4.3 ± 0.8 4.2 ± 0.8
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Age (y) 54.5 ± 9.2 58.7 ± 9.2 54.0 ± 9.2 58.2 ± 9.2 55.2 ± 9.3 59.4 ± 9.3
Hypertension (%) 29.5 39.7 28.9 38.0 30.4 42.4
Diabetes (%) 8.5 13.0 4.9 9.6 14.3 ** 18.3 **
Hyperlipidemia (%) 21.7 40.6 20.9 40.5 23.3 40.6
Obesity (BMI≥ 25 kg/m2) (%) 31.0 41.6 27.6 34.6 46.0 ** 54.8 **
Ex- and current smoker (%) 16.3 19.6 3.4 4.0 40.2 ** 44.2 **
MAP (mmHg) 88.8 ± 10.3 85.2 ± 9.6 88.2 ± 10.7 83.9 ± 9.6 89.6 ± 9.6 87.3 ± 9.2 **
FBS (mg/dL) 103.7 ± 23.2 99.5 ± 22.0 101.2 ± 20.4 98.0 ± 23.5 107.7 ± 26.6 ** 101.7 ± 19.2
TC (mg/dL) 200.5 ± 37.4 206.3 ± 36.0 203.8 ± 35.8 209.3 ± 35.3 195.2 ± 39.3 * 201.7 ± 36.7 *
TG (mg/dL) 120.8 ± 72.1 120.1 ± 71.6 112.6 ± 66.5 114.2 ± 70.0 133.63 ± 78.76 ** 129.5 ± 73.4 *
HDL-C (mg/dL) 56.4 ± 15.0 57.6 ± 14.5 60.7 ± 15.7 61.9 ± 14.7 49.6 ± 10.9 ** 50.8 ± 11.2 **
BMI (kg/m2) 24.3 ± 3.2 24.7 ± 3.4 23.7 ± 3.1 24.0 ± 3.3 25.3 ± 3.1 ** 25.7 ± 3.3 **
Arterial stiffness
PWV (m/s) 6.1 ± 1.1 6.9 ± 1.2 6.0 ± 1.1 6.7 ± 1.1 6.3 ± 1.2 ** 7.2 ± 1.3 **
EP (kPa) 104.7 ± 43.3 135.8 ± 53.3 100.8 ± 41.1 130.2 ± 48.6 110.9 ± 46.1 ** 144.7 ± 59.0 **
β 8.0 ± 2.9 10.9 ± 3.8 7.7 ± 2.6 10.6 ± 3.5 8.4 ± 3.2 ** 11.4 ± 4.2 *
Progression rate of arterial stiffness
ΔPWV/yr (m/s/yr) 0.19 ± 0.20 0.18 ± 0.20 0.20 ± 0.20
ΔEP/yr (kPa/yr) 7.44 ± 8.43 6.98 ± 8.26 8.17 ± 8.65
Δβ/yr 0.68 ± 0.59 0.67 ± 0.56 0.70 ± 0.64
BMI body mass index, FBS fasting blood sugar, MAP mean arterial pressure, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol
*P <0.05, **P < 0.01, in comparison between men and women using Student’s t test or Chi-squared test
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study participants. The average interval between two
ultrasonography examinations was 4.2 ± 0.8 years. At
baseline, men had a higher proportion of diabetes and
smoking habit and were more obese than women. Men
had higher values of FBS, TG and BMI, while women
had higher values of HDL-C and TC. The above patterns
remained in the second measure.
For both baseline and follow-up data, men had sig-
nificantly higher values of PWV, Ep and β in compari-
son to women (Table 1). The progression rates of PWV,
Ep and β were faster in men, but the difference was not
statistically significant (Fig. 1). The three stiffness pa-
rameters were strongly correlated with each other, and
there was an inverse correlation between the stiffness
parameters at baseline and their progression rates
(Table 2). For example, a higher value of PWV at base-
line (i.e., stiffer arteries) was associated with a slower
progression rate of PWV at follow-up.
Cardiovascular risk factors and stiffness progression
Conventional risk factors including diabetes, hypertension
and obesity were associated with more advanced stiffness
at baseline (Additional file 1: Table S1). However, these
baseline risk factors did not significantly predict progres-
sion rate in any of the three parameters. Each risk factor
was associated with faster progression rate in men than in
women, but the differences did not reach any statistical
significance (Additional file 1: Table S2).
We further used Pearson’s correlation to evaluate the
relationship between quantitative risk factors and stiff-
ness progression rate with the adjustment of age and sex
(Table 2). Only baseline MAP and BMI were correlated
to the stiffness progression rates. The changes in MAP
(ΔMAP) and TC (ΔTC) during the follow-up period
were significantly correlated with the progression rates
of PWV and Ep. Furthermore, changes in BMI (ΔBMI)
and TG (ΔTG) were associated with the progression
rates of PWV and Ep with borderline p values < 0.10.
Independent predictors of stiffness progression
Stepwise multivariate regression analyses were conducted
to identify the independent predictors of stiffness progres-
sion. Only risk factors that were related to the progression
rates in the initial analyses with p values < 0.10 were in-
cluded. Age, baseline stiffness parameters, baseline MAP,
baseline BMI and changes in MAP (ΔMAP) were found
to be independent predictors of PWV and Ep progression
(Table 3). In fact, ΔMAP was more strongly associated
with PWV progression than baseline MAP. Similar find-
ings were also noted for the rate of Ep progression but not
for the rate of β progression. Although changes in plasma
TC and TG levels were associated with stiffness progres-
sion in the univariate analysis, the significance disappeared
after adjustment for other risk factors. Baseline BMI and
change in BMI (ΔBMI) were significantly associated with
a faster progression of PWV, Ep and β in men but not in
women.
To further delineate the relationship between ΔMAP
and stiffness progression, study subjects were divided into
two groups based on the increase or decrease of MAP
during the follow-up period. Figure 2 showed that an
increase in MAP (ΔMAP> 0 mmHg) during the follow-up
period was significantly associated with a more rapid pro-
gression rate of PWV in both hypertensive subjects and in
normotensive subjects. A similar pattern was also ob-
served in Ep but not in β. More specifically, baseline MAP
and ΔMAP were not related to β progression.
Discussion
The present study reported the progression rate of ca-
rotid stiffness in a Chinese population during an average
follow-up of 4.1 years. Although men tended to have
faster progression of all of the stiffness parameters rela-
tive to women, the difference did not reach statistical
significance. Conventional risk factors including hyper-
tension, diabetes, obesity, and serum lipid profile were
correlated with a stiffer artery at baseline, but they were
Fig. 1 Sex-specific progression rates of (a) PWV (b) Ep and (c) β in different age groups
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Table 2 Pearson’s correlation coefficient (r) between risk factors and progression rate of arterial stiffness
Stiffness parameters at baseline Progression rate of stiffness parameters
PWV Ep β ΔPWV/yr ΔEP/yr Δβ/yr
PWV – 0.97 ** 0.93 ** - 0.33 ** - 0.18 ** - 0.10 *
EP – – 0.95 ** - 0.34 ** - 0.19 ** - 0.09 *
β – – – - 0.30 ** - 0.17 ** - 0.12 *
MAP 0.44 ** 0.41 ** 0.12 ** - 0.17 ** - 0.08 * 0.04
FBS 0.09 * 0.09 * 0.09 * 0.04 0.05 0.06
TG 0.26 ** 0.21 ** 0.16 ** 0.02 0.03 0.07
HDL-C - 0.21 ** - 0.21 ** - 0.17 ** 0.04 0.02 - 0.02
BMI 0.30 * 0.26 ** 0.21 ** 0.03 0.08 * 0.10 *
ΔMAP – – – 0.42 ** 0.38 ** - 0.004
ΔTC – – – 0.13 ** 0.11 * 0.06
ΔTG – – – 0.08 * 0.08 * 0.04
ΔBMI – – – 0.08 * 0.08 * 0.05
Number in the table is partial Pearson’s correlation coefficient (r) with adjustment of age and sex
ΔMAP, ΔFBS, ΔTC, ΔTG, ΔHDL-C, and ΔBMI are calculated by subtracting the values at follow-ups by the corresponding values at baseline
TG was log-transformed to approximate the normal distribution. Variables (TC, ΔHDL-C, and ΔFBS) not associated with any stiffness parameter were not shown
* = p < 0.10, ** = p < 0.01
Table 3 Predictors of stiffness progression rate by multivariate regression analysis
Covariates All (N = 577) Women (N = 353) Men (N = 224)
PWV progression Coefficient (SE) p value Coefficient (SE) p value Coefficient (SE) p value
Age 0.007 (0.001) <0.001 0.008 (0.001) <0.001 0.007 (0.002) <0.001
Male - 0.008 (0.016) 0.604 – – – –
Baseline PWV (m/s) - 0.075 (0.008) <0.001 - 0.086 (0.010) <0.001 - 0.059 (0.012) <0.001
MAP (mmHg) 0.004 (0.001) <0.001 0.006 (0.001) <0.001 – –
BMI (kg/m2) 0.008 (0.002) 0.002 – – 0.012 (0.005) 0.011
ΔMAP (mmHg) 0.010 (0.001) <0.001 0.010 (0.001) <0.001 0.008 (0.002) <0.001
ΔBMI (kg/m2) – – 0.024 (0.010) 0.013
Ep progression Coefficient (SE) p value Coefficient (SE) p value Coefficient (SE) p value
Age (y) 0.369 (0.039) <0.001 0.412 (0.049) <0.001 0.349 (0.066) <0.001
Male - 0.748 (0.679) 0.271 – – – –
Baseline Ep (kPa) - 0.060 (0.009) <0.001 - 0.072 (0.012) <0.001 - 0.050 (0.015) 0.001
MAP (mmHg) 0.194 (0.042) <0.001 0.251 (0.050) <0.001 0.163 (0.074) 0.028
BMI (kg/m2) 0.327 (0.108) 0.003 – – 0.473 (0.191) 0.014
ΔMAP (mmHg) 0.401 (0.041) <0.001 0.420 (0.049) <0.001 0.360 (0.074) <0.001
ΔBMI (kg/m2) – – – – 0.916 (0.409) 0.026
β progression Coefficient (SE) p value Coefficient (SE) p value Coefficient (SE) p value
Age (y) 0.028 (0.003) <0.001 0.030 (0.004) <0.001 0.028 (0.005) <0.001
Male - 0.052 (0.052) 0.318 – – – –
Baseline β - 0.041 (0.010) <0.001 - 0.042 (0.012) 0.001 - 0.045 (0.015) 0.004
MAP (mmHg) – – – –
BMI (kg/m2) 0.024 (0.008) 0.003 – – 0.038 (0.015) 0.010
ΔMAP (mmHg) – – – – – –
ΔBMI (kg/m2) – – – – 0.078 (0.032) 0.015
Covariates included in the stepwise multivariate regression model were age at baseline, sex, baseline stiffness parameters, MAP at baseline, BMI at baseline,
ΔMAP, ΔTC, ΔTG and ΔBMI. Only variates with significant p value were retained in the final model
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not associated with any stiffness progression rates. The
major determinants of the stiffness progression rate were
(1) age, (2) severity of stiffness at baseline, (3) baseline
MAP and ΔMAP, and (4) baseline BMI. Additionally,
gain of BMI during the follow-up period was signifi-
cantly associated with a faster progression in men, but
not in women.
In this study, three stiffness parameters (Ep, β, and
PWV) were used to measure the arterial stiffness. Al-
though the three parameters are well correlated, they
reflect different aspects of vascular property. PWV is
generally considered to be the gold standard measure
of systemic arterial stiffness [22, 23], whereas Ep and β
are determinants of local vessel wall elasticity [22, 24].
Ep is vulnerable to the effect of pulse pressure, while β
is the natural logarithm of SBP and DBP ratio and thus
is relatively independent of BP [25, 26]. That explains
why MBP was significantly correlated with PWV and
Ep, but not associated with β in the current study. To
be noticed, one-point carotid PWV instead of carotid-
femoral PWV was measured by ultrasound with an
echo-tracking system in the present study. The validity
of one-point carotid PWV was supported by literature
that demonstrated a good correlation between one-
point measurement and the conventional carotid-
femoral PWV [20, 27].
The present study is the largest Chinese cohort with lon-
gitudinal follow-up data of arterial stiffness. The average
value of baseline PWV in the present study (6.1 ± 1.1 m/s)
was close to that of one previous report measuring one-
point carotid PWV (6.1 ± 1.2 m/s) [19] and was slightly
lower than those of previous reports investigating carotid-
femoral PWV (7.2–9.7 m/s) in Chinese populations [28,
29]. It appeared that Chinese patients had lower PWV
values than Caucasians (8.6–11.40 m/s) [12, 30]. The me-
dian value of one-point carotid PWV (5.8 m/s) was
systemically lower than that of carotid-femoral PWV
(7.2 m/s) [27], possibly explaining why we observed a
lower average value. The progression rate of PWV in
the Caucasian population varied greatly among studies
(0.14 ± 0.22–0.29 ± 0.31 m/s/yr) [15, 30]. Further in-
vestigations are needed to validate the progression
rate found in our population (0.19 ± 0.20 m/s/yr).
Arterial stiffening is one of the manifestations of vascu-
lar aging. The Framingham Heart Study showed that aging
is strongly correlated with stiffer arteries [31]. Our longitu-
dinal cohort study further demonstrated that aging is not
only associated with arterial stiffness at a cross-sectional
time point, but was also related to the acceleration of stiff-
ness progression, in accordance with several other longitu-
dinal studies [11, 13, 32]. In the MESA study, the rate of
progression became steeper in subjects older than 75 years
old [13]. Similarly, our cohort found that subjects aged ≥
70 years had significantly faster stiffness progression rates
than those in other age groups (Additional file 1: Table
S3). In line with previous reports [11, 33], stiffness pro-
gression rates were found to be similar between men and
women in our population. According to the Baltimore
Longitudinal Study of Aging, the progression rates be-
tween sexes were different in elderly populations but simi-
lar in young subjects [12]. Although men tended to have
faster progression rates than women in our subjects aged ≥
70 years (Fig. 1), a small sample size in this age group lim-
ited the statistical power to distinguish whether the differ-
ence was substantial.
There was an inverse correlation between the stiffness
parameters at baseline and their progression rate at
follow-up. In other words, a worse stiffness profile at base-
line was associated with a slower progression rate, rather
than a faster progression rate. In agreement with our find-
ings, Wildman et al. also found baseline aortic PWV
(aPWV) was negatively associated with annual changes in
aPWV [33]. Moreover, an inverse correlation was found
between baseline carotid intima-media thickness (IMT)
Fig. 2 Fair-controlled blood pressure during follow-up period is associated with slower progression rate of (a) PWV (b) Ep and (c) β in hypertensive
and normotensive subjects
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and IMT progression in the Young Finns Study [34]. This
reverse relationship represents a ceiling effect of arterial
stiffness, which indicates that stiffer arteries have less
physiological room for further progression [13].
Our data suggested that elevated BP at baseline and dur-
ing follow-up were two independent predictors of stiffness
progression, with increases in BP during follow-up being
the stronger of the two (Table 3). Poorly controlled BP
was reported to lead to a PWV progression rate that was
three times faster in hypertensive patients than in those
with well-controlled BP [11]. In our cohort, we found that
increases in BP have a deleterious influence on stiffness
progression for both hypertensive and normotensive sub-
jects (Fig. 2). This supported the previous findings that
pre-hypertension (SBP/DBP = 120-139/80-89 mmHg) as
well as clinically defined hypertension were both risk
factors for stiffness progression [12, 32]. We also found
that the stiffness progression rate was similar between
normotensive subjects and treated hypertensive subjects
(Additional file 1: Table S4). However, subjects with poorly
controlled BP during follow-up had faster stiffness pro-
gression whether they were normotensive or hypertensive
at baseline. In addition, there was a reciprocal relationship
between stiffness parameters and BP. Elevated PWV was
found to be a predictor of longitudinal BP changes and
incident hypertension [35], while high BP causes blood
vessels to lose their elasticity, which in turn makes the
control of BP more difficult. Therefore, early intervention
to control BP is an important step to maintain the elasti-
city of blood vessels.
Obesity has been recognized as a risk factor for arterial
stiffness in cross-sectional studies [36]. One longitudinal
study showed that both baseline BMI and BMI changes
were independently associated with an increase in aortic
PWV in both men and women [33]. However, our data
only suggested that male arterial stiffness was influenced
by baseline BMI and BMI changes. Because there was a
smaller change of BMI in women relative to men
(ΔBMI = 0.32 ± 1.4 in women and 0.48 ± 1.3 kg/m2 in
men, respectively), it was difficult to observe a signifi-
cant effect of ΔBMI on stiffness progression in females.
There were several limitations in the present study. We
used one-point carotid PWV rather than the gold stand-
ard measure of carotid-femoral PWV. Although the two
parameters are highly correlated [20, 27], they are not
interchangeable, prohibiting head-to-head comparison
between our data and other studies. The relationship
between medication and the stiffness progression rate was
not investigated due to incomplete information concern-
ing medication. However, this study emphasizes the rela-
tionship between BP control and stiffness progression,
rather than the drug effect of individual anti-hypertensive
agents. Although MBP rather than SBP/DBP is used in
our regression model, the relationships between BP and
stiffness progression are identical for the three BP mea-
surements. We acknowledged that the utilized sample
size and duration of follow-up might have limit the
power to detect a risk factor with a modest effect, espe-
cially for sex-specific analyses. However, our sample size
was comparable with previous cohorts [11, 12, 15], and
our results are consistent with these previous studies.
Conclusions
The present study delineated the progression rate of arter-
ial stiffness and predictors of stiffness progression in a
Chinese population. Aging and elevated blood pressure at
baseline and during follow-up were the major determi-
nants of stiffness progression in this Han Chinese popula-
tion. For men, increased baseline BMI and changes in
BMI were additional risk factors.
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